AI Spotlight on PDEX
Company Description
Pro-Dex, Inc.designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide.The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.
It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries.The company was founded in 1978 and is headquartered in Irvine, California.
Market Data
Last Price | 37.97 |
Change Percentage | -11.59% |
Open | 43.07 |
Previous Close | 42.95 |
Market Cap ( Millions) | 124 |
Volume | 98192 |
Year High | 59.6 |
Year Low | 16.18 |
M A 50 | 47.37 |
M A 200 | 29.17 |
Financial Ratios
FCF Yield | 2.11% |
Dividend Yield | 0.00% |
ROE | 21.68% |
Debt / Equity | 54.45% |
Net Debt / EBIDTA | 148.52% |
Price To Book | 3.89 |
Price Earnings Ratio | 18.35 |
Price To FCF | 47.42 |
Price To sales | 2.03 |
EV / EBITDA | 12.13 |
News
- 01:40 - Q4 2024 Portfolio Update: Growth Has Come Patiently
- Jan -30 - Pro-Dex, Inc. (PDEX) Surpasses Q2 Earnings and Revenue Estimates
- Jan -30 - Pro-Dex, Inc. Announces Fiscal 2025 Second Quarter and Six-Month Results
- Jan -28 - All You Need to Know About ProDex (PDEX) Rating Upgrade to Buy
- Jan -07 - ProDex (PDEX) Moves 23.0% Higher: Will This Strength Last?
- Jan -07 - Pro-Dex Stock Skyrockets Over the Past Year: A Must Buy?
- Jan -06 - Best Momentum Stocks to Buy for January 6th
- Jan -06 - New Strong Buy Stocks for January 6th
- Oct -31 - PRO-DEX, INC. Announces Fiscal 2025 First Quarter Results
- Oct -02 - Pro-Dex Inc (PDEX) Stock Price Up 3.99% on Oct 2
- Sep -06 - Pro-Dex Q4 Earnings Rise Y/Y, Sales Surge on Customer Growth
- Sep -05 - Pro-Dex, Inc. Announces Fiscal 2024 Fourth Quarter and Full-Year Results
- Aug -08 - Zacks Initiates Coverage of Pro-Dex With Outperform Recommendation
- May -02 - Pro-Dex, Inc. Announces Fiscal 2024 Third Quarter And Nine-Month Results
- Feb -08 - Pro-Dex, Inc. Announces Fiscal 2024 Second Quarter and Six-Month Results
- Dec -17 - 3 Very Undervalued Stocks With Strong Growth Prospects
- Nov -02 - Pro-Dex, Inc. Announces Fiscal 2024 First Quarter Results
- Oct -26 - Pro-Dex, Inc. Discusses 4th Quarter and Year-End Results with The Stock Day Podcast
- Jul -13 - Sopheon Expands into Asia and South Pacific with Acquisition of Prodex Systems
- Nov -24 - 3 Ways To Beat The Tax Man: Amplify Energy, Pro-Dex And 1847 Goedeker
Business Breakdown
Expected Mid-Term Growth
Segment nΒ°1 -> Medical Devices
Expected Growth : 3.5 %
What the company do ?
Pro-Dex, Inc. designs and manufactures medical devices, including surgical and orthopedic instruments, and implantable devices for various medical specialties.
Why we expect these perspectives ?
Pro-Dex, Inc.'s medical devices segment growth of 3.5% is driven by increasing demand for minimally invasive surgical instruments, expansion into emerging markets, and strategic partnerships. Additionally, advancements in robotics and artificial intelligence are fueling innovation, while an aging population and rising healthcare expenditure support sustained growth.
Segment nΒ°2 -> Repairs
Expected Growth : 3.2 %
What the company do ?
Repairs from Pro-Dex, Inc. offers repair services for medical devices, including surgical and anesthesia equipment, to extend their lifespan and ensure optimal performance.
Why we expect these perspectives ?
Pro-Dex, Inc.'s 3.2% growth in repairs is driven by increasing demand for medical devices, expansion into new markets, and strategic partnerships. Additionally, the company's focus on quality and customer satisfaction has led to repeat business and positive word-of-mouth, contributing to the growth.
Segment nΒ°3 -> NRE & Prototype
Expected Growth : 3.8 %
What the company do ?
NRE (Non-Recurring Engineering) and Prototype from Pro-Dex, Inc. refer to the initial product development phase, where a single unit or a small batch of a product is manufactured for testing and validation purposes.
Why we expect these perspectives ?
Pro-Dex Inc.'s NRE & Prototype segment growth of 3.8% is driven by increasing demand for medical devices, expansion into new markets, and investments in research and development. Additionally, the company's focus on innovation and quality has led to higher customer retention rates and new business opportunities.
Segment nΒ°4 -> Discounts & Other
Expected Growth : 2.8 %
What the company do ?
Discounts & Other from Pro-Dex, Inc. refers to miscellaneous revenue streams, including discounts, rebates, and other non-operating income.
Why we expect these perspectives ?
Pro-Dex, Inc.'s 2.8% growth in Discounts & Other is driven by increasing sales of medical device components, expansion into new markets, and strategic partnerships. Additionally, the company's focus on operational efficiency and cost reduction initiatives have contributed to the growth. Furthermore, the company's ability to negotiate better prices with suppliers has also positively impacted the segment.
Segment nΒ°5 -> Industrial and Scientific
Expected Growth : 3.9 %
What the company do ?
Industrial and Scientific from Pro-Dex, Inc. provides precision-engineered products and solutions for medical, scientific, and industrial applications.
Why we expect these perspectives ?
Pro-Dex Inc.'s Industrial and Scientific segment growth of 3.9% is driven by increasing demand for precision-engineered products, expansion into new markets, and strategic partnerships. Additionally, investments in research and development, coupled with a strong focus on innovation, have enabled the company to capitalize on emerging trends in the industrial and scientific sectors.
Segment nΒ°6 -> Dental and Component
Expected Growth : 3.6 %
What the company do ?
Pro-Dex, Inc.'s Dental and Component segment offers dental and surgical instruments, including endodontic and orthodontic instruments, and component parts for medical devices.
Why we expect these perspectives ?
Pro-Dex, Inc.'s Dental and Component segment growth of 3.6% is driven by increasing demand for dental implants, rising adoption of digital dentistry, and growing need for precision-engineered components in medical devices. Additionally, the company's focus on innovation, quality, and customer service has led to market share gains and expansion into new geographies.
Pro-Dex, Inc. Products
Product Range | What is it ? |
---|---|
Medical Device Products | Pro-Dex, Inc. designs and manufactures medical device products, including surgical and orthopedic instruments, and implantable devices. |
Laser Machining Services | Pro-Dex, Inc. offers laser machining services for precision cutting, drilling, and welding of medical devices and instruments. |
Clean Room Assembly and Packaging | Pro-Dex, Inc. provides clean room assembly and packaging services for medical devices, ensuring sterile and contamination-free products. |
Engineering and Design Services | Pro-Dex, Inc. offers engineering and design services for medical devices, including design, development, and testing. |
Pro-Dex, Inc.'s Porter Forces
Threat Of Substitutes
Pro-Dex, Inc. operates in a niche market with limited substitutes, but the threat of substitutes is still present due to the evolving nature of the medical device industry.
Bargaining Power Of Customers
Pro-Dex, Inc. has a diverse customer base, which reduces the bargaining power of individual customers. Additionally, the company's products are critical to its customers' operations, making it difficult for customers to negotiate prices.
Bargaining Power Of Suppliers
Pro-Dex, Inc. relies on a few key suppliers for critical components, giving them some bargaining power. However, the company's strong relationships with suppliers and its ability to negotiate contracts mitigate this risk.
Threat Of New Entrants
The medical device industry has high barriers to entry, including regulatory hurdles and significant capital requirements, making it difficult for new entrants to compete with Pro-Dex, Inc.
Intensity Of Rivalry
The medical device industry is highly competitive, with several established players competing for market share. Pro-Dex, Inc. must continually innovate and improve its products to maintain its market position.
Capital Structure
Value | |
---|---|
Debt Weight | 31.89% |
Debt Cost | 4.80% |
Equity Weight | 68.11% |
Equity Cost | 6.69% |
WACC | 6.09% |
Leverage | 46.82% |
Pro-Dex, Inc. : Quality Control
Pro-Dex, Inc. passed 6 out of 9 key points:
Historical Valuation
Price/Earnings Ratio
Margin Valuation
Peers Valuation
Competitors
Company | Rational |
---|---|
NEPH | Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and β¦ |
OSUR | OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in β¦ |
WRBY | Warby Parker Inc. provides eyewear products. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as accessories, including cases, lenses kit with anti-fog spray, pouches, and β¦ |
LMAT | LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing β¦ |
UTMD | Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD β¦ |